Edesa Biotech Inc (EDSA)

3.60 -0.03  -0.82% NASDAQ Feb 21, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events


Date Type Description
02/05/2020 Earnings Edesa Biotech Inc First Quarter Earnings Results in 2020
12/12/2019 Earnings Edesa Biotech Inc Fourth Quarter Earnings Results for 2019
12/12/2019 Misc Edesa Biotech Inc Annual Report for 2019
08/14/2019 Earnings Edesa Biotech Inc Third Quarter Earnings Results in 2019
06/10/2019 Splits Ratio: 1666667:10000000
05/08/2019 Earnings Edesa Biotech Inc Second Quarter Earnings Results in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: http://www.edesabiotech.com
  • Investor Relations URL: http://ir.stellarbiotechnologies.com/
  • HQ State/Province: Ontario
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Feb. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Edesa Biotech Inc is a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.